NASDAQ: CGON
Cg Oncology Inc Stock Ownership - Who owns Cg Oncology?

Insider buying vs selling

Have Cg Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Leonard E. PostDirector2025-04-281,000$0.60
$600.00Buy
Leonard E. PostDirector2025-04-281,000$30.76
$30.76kSell
Leonard E. PostDirector2025-03-171,000$0.60
$600.00Buy
Leonard E. PostDirector2025-03-171,000$28.00
$28.00kSell
Leonard E. PostDirector2025-02-181,000$0.60
$600.00Buy
Leonard E. PostDirector2025-02-181,000$28.61
$28.61kSell
Leonard E. PostDirector2025-01-131,000$29.66
$29.66kSell
Leonard E. PostDirector2025-01-131,000$0.60
$600.00Buy
Hong Fang SongDirector2024-12-16700,000$28.00
$19.60MSell
Leonard E. PostDirector2024-12-161,000$0.60
$600.00Buy

1 of 2

CGON insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGON insiders and whales buy or sell their stock.

CGON Shareholders

What type of owners hold Cg Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital LLC8.36%6,371,669$178.22MInstitution
Vanguard Group Inc7.69%5,861,082$163.93MInstitution
Decheng Capital Global Life Sciences Fund IV LP7.03%5,358,810$149.89MInsider
Hong Fang Song5.52%4,204,841$117.61MInsider
Blackrock Inc5.33%4,061,130$113.59MInstitution
Tcg Crossover Management LLC4.82%3,670,206$102.66MInstitution
Braidwell LP4.31%3,283,317$91.83MInstitution
Kynam Capital Management LP3.31%2,519,705$70.48MInstitution
Fmr LLC3.19%2,433,593$68.07MInstitution
Foresite Capital Management VI LLC2.91%2,221,474$62.13MInstitution

1 of 3

CGON vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGON86.88%12.60%Net SellingNet Buying
NAMS70.81%29.19%Net SellingNet Selling
MIRM50.40%49.60%Net SellingNet Selling
AAPG0.00%0.00%
BLTE0.89%0.00%

Cg Oncology Stock Ownership FAQ

Who owns Cg Oncology?

Cg Oncology (NASDAQ: CGON) is owned by 86.88% institutional shareholders, 12.60% Cg Oncology insiders, and 0.52% retail investors. Decheng Capital Global Life Sciences Fund IV LP is the largest individual Cg Oncology shareholder, owning 5.36M shares representing 7.03% of the company. Decheng Capital Global Life Sciences Fund IV LP's Cg Oncology shares are currently valued at $144.37M.

If you're new to stock investing, here's how to buy Cg Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.